Subcutaneous Route and Pharmacology of Metoclopramide
NCT02466984
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Nausea
Vomiting
Interventions
DRUG:
metoclopramide intravenous
Sponsor
University Hospital, Bordeaux